Greenberg Traurig’s Barry Schindler to Speak on AIA Post-Grant Proceedings in Live Webcast

Share Article

Barry Schindler, co-chair of the Global Patent Prosecution Group in the Intellectual Property & Technology Practice at international law firm Greenberg Traurig, LLP, will speak during The Knowledge Group’s two-hour live webcast titled, “AIA Post-Grant Proceedings: Uncovering the Implications of the New AIA Review Rules,” from 12– 2 p.m. EST on August 17.

Barry Schindler, co-chair of the Global Patent Prosecution Group in the Intellectual Property & Technology Practice at international law firm Greenberg Traurig, LLP, will speak during The Knowledge Group’s two-hour live webcast titled, “AIA Post-Grant Proceedings: Uncovering the Implications of the New AIA Review Rules,” from 12– 2 p.m. EST on August 17. Schindler is a shareholder in the firm’s New Jersey office. More information on the speakers and the webcast can be found here.

The course will provide an in-depth discussion of how the America Invents Act (AIA) continues to bring in significant changes to the patent system. Leaders and practitioners assembled by The Knowledge Group will help firms and individuals better understand the implications of the new rules and how they will affect strategies for both petitioners and patent owners moving forward.

Key topics include: patent owner submission of new testimonial evidence with preliminary response; proper use of new (non-petition cited) evidence in post-grant proceedings; Phillips-like claim construction for patent claims that expire before the proceeding concludes; sufficiency of evidence to show a motivation to combine to establish a prima facie case of obviousness; practice tips for expert declarations in AIA post grant proceedings; strategic consideration regarding petitioner’s expert rebuttal declaration; word-count limits instead of page-count limits for major briefing; strategic considerations in preparing for oral argument; and Rule 11- type certifications for papers filed in proceedings. Registration for this webcast can be found here.

Schindler has more than 25 years of legal experience in all aspects of pharmaceutical and chemical patent prosecution, representing numerous major pharmaceutical and chemical companies regarding patents relating to small molecules and synthetic compounds. Schindler has experience in PGR proceedings as lead counsel on dozens of proceedings. Schindler also has wide-ranging patent experience in such areas as medical devices, business method processes, food products/supplements, telemedicine, internet-based systems, and plastics and has provided counsel to some of the world's most innovative corporations in such areas.

About Greenberg Traurig’s Intellectual Property & Technology Practice
With more than 180 intellectual property attorneys and agents in the United States, Asia, and Europe, Greenberg Traurig provides a broad range of patent, trademark and copyright protection and strategic counseling. Greenberg Traurig was named a “National Tier 1” Law Firm for IP Litigation, Patent Law, Trademark and Information Technology Law by U.S. News and Best Lawyers, 2013 “Best Law Firms Rankings.”

About Greenberg Traurig, LLP
Greenberg Traurig, LLP is an international, multi-practice law firm with approximately 2000 attorneys serving clients from 38 offices in the United States, Latin America, Europe, Asia, and the Middle East. The firm is No 1. on the 2015 Law360 Most Charitable Firms list, second largest in the U.S. on the 2016 Law360 400, Top 20 on the 2015 Am Law Global 100, and among the 2015 BTI Brand Elite. More information at: http://www.gtlaw.com/.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lourdes Brezo-Martinez
@GT_Law
Follow >
Visit website